Radiopharmaceuticals 2025–2026: Why Cost, Infrastructure, and Workflow Now Matter More Than Novelty
Radiopharmaceuticals innovation in 2026 have moved decisively beyond their historical niche in nuclear medicine. What was once a specialised diagnostic […]










